Connect with us

JAMMU & KASHMIR

DAK skeptical of Russian COVID-19 vaccine | KNO

Published

on

kno news

Srinagar, Aug 12 (KNO): While Russia has approved the world’s first COVID-19 vaccine for public use, Doctors Association Kashmir (DAK) on Wednesday said they are skeptical about the claim as the vaccine has been granted license for civilian use even before the clinical trials are completed. “Mass vaccination with an incompletely tested vaccine is unethical,” said DAK President and influenza expert Dr Nisar ul Hassan in a statement issued to the news agency—Kashmir News Observer (KNO). “Russia has conducted just two trials of the vaccine with the third clinical trial yet to start,” he said. “The normal approval process of a new vaccine is to gather data from phase 1 and phase 2 clinical trials and then expand the pool of study participants in phase 3 to create enough evidence that the vaccine is effective and safe. Dr Nisar said to fully assess the efficacy and safety of a vaccine phase 3 trials are required. “The phase 3 trial is the pivotal study on which the decision on whether to grant the license is based,” he said. He said Russia has not made data from the earlier trials public and the data has not been peer-reviewed which is important for regulatory approval. “Lack of published data on vaccine - including how it is made and details on safety, immune response and whether it can prevent COVID-19 infection has left health experts and the public across the globe in dark,” he added. Dr Nisar said the rush to start using the vaccine before phase 3 trials, which normally lasts for months and involve thousands of people could backfire. “One of the biggest concerns about approving a new vaccine before clinical trials are complete is that it could jeopardize public trust in the vaccine development process and people may not use it,” he said. “Even the Moscow-based Association of Clinical Trials Organization, a trade body representing the world’s top drug makers in Russia had urged the Russian health ministry to postpone vaccine approval until the final trial is successfully completed. The World Health Organization has made it clear that any WHO stamp of approval on Russia’s COVID-19 vaccine would require a rigorous safety data review,” said Dr Nisar—(KNO) 

Trending

TOP STORIES8 hours ago

On Doctors’ Day, J&K’s medical fraternity highlights challenges amid dedication to service | KNO

TOP STORIES8 hours ago

Reopen cases of victims killed by Pak based terrorists: LG Sinha to security agencies | KNO

TOP STORIES8 hours ago

Div Com, IGP Kashmir hold meeting with Shia Associations | KNO

TOP STORIES8 hours ago

LG visits Yatri Niwas at Bhagwati Nagar Jammu | KNO

TOP STORIES8 hours ago

Houseboat Association, Dal dwellers call on CM Omar | KNO

TOP STORIES8 hours ago

LG reviews final preparations for SANJY-2025 | KNO

TOP STORIES8 hours ago

LG chairs high-level meeting, discusses issues of terror victim families | KNO

TOP STORIES8 hours ago

LG flags off fleet of ambulances for Hospitals in Ramban, Anantnag | KNO

TOP STORIES8 hours ago

Mirwaiz grieved over demise of Ghulam Mohammad Baig | KNO

TOP STORIES9 hours ago

SANJY-2025: Traffic plan for Sgr-Jmu NH issued for tomorrow | KNO

TOP STORIES9 hours ago

ACB books DDC member, his tout in bribery case | KNO

TOP STORIES9 hours ago

F&ES Recruitment Scam: ACB says committed to deliver justice | KNO

TOP STORIES9 hours ago

CBK produces charge-sheet against Kokernag resident | KNO

TOP STORIES9 hours ago

Police establish helpline for victims of terrorism in Awantipora | KNO

TOP STORIES9 hours ago

Haryana resident held for using fake yatra card to bypass security barriers: Police | KNO

TOP STORIES9 hours ago

Amarnath Yatra 2025: LG Sinha to flag off first batch of pilgrims from Jammu tomorrow | KNO

TOP STORIES9 hours ago

GST reshaped India’s economic landscape: PM Modi | KNO

Copyright © 2021